Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mélanie White-Koning"'
Autor:
Félicien Le Louedec, Florent Puisset, Fabienne Thomas, Étienne Chatelut, Mélanie White‐Koning
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1208-1220 (2021)
Abstract Pharmacokinetic (PK) parameter estimation is a critical and complex step in the model‐informed precision dosing (MIPD) approach. The mapbayr package was developed to perform maximum a posteriori Bayesian estimation (MAP‐BE) in R from any
Externí odkaz:
https://doaj.org/article/c86571642f3042ac94a9ffd97f1904dc
Autor:
Félicien Le Louedec, Fanny Gallais, Fabienne Thomas, Mélanie White-Koning, Ben Allal, Caroline Protin, Loïc Ysebaert, Étienne Chatelut, Florent Puisset
Publikováno v:
Pharmaceuticals, Vol 14, Iss 2, p 162 (2021)
Therapeutic drug monitoring of ibrutinib is based on the area under the curve of concentration vs. time (AUCIBRU) instead of trough concentration (Cmin,ss) because of a limited accumulation in plasma. Our objective was to identify a limited sampling
Externí odkaz:
https://doaj.org/article/55cf8a5bddb5425db85465e59fc53d4c
Autor:
Florent Puisset, Félicien Le Louedec, Florence Dalenc, Lorène Verguet, Eleonora De Maio, Jean Louis Lacaze, Marion Montastruc, Mony Ung, Camille Vinson, Sophie Perriat, Sandrine Pacher, Etienne Chatelut, Mélanie White Koning
Publikováno v:
British Journal of Clinical Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36bb36b307ab21503bf242bf308eba95
https://doi.org/10.1111/bcp.15702
https://doi.org/10.1111/bcp.15702
Autor:
Emmanuel, Curis, Hélène, Fenet, Pascale, Friant-Michel, Julien, Godet, Marie-Paule, Gustin, Alexandrine, Lambert, Ioannis, Nicolis, Mélanie, White-Koning, Sarah, Ayraud-Thévenot, Emmanuelle, Barron, Frédérique, Courant, Catherine, Dumartin, Geoffroy, Duporté, Aurélie, Escande, Stephan, Gabet, Anne, Garat, Béatrice, Grave, Mathieu, Guerriaud, Blandine, Juillard-Condat, Pierre, Lebailly, Géraldine, Leguelinel-Blache, Guillaume, Monziols, Thomas, Morgenroth, Catherine, Mullié, Ndeye Coumba, Ndiaye, Lydia, Nikasinovic, Lucie, Oziol, Daniel, Perdiz, Hélène, Peyriere, Stéphanie, Ragot, Fanny, Rancière, Céline, Roda, Marie-Pierre, Sauvant-Rochat, Nathalie, Thilly
Publikováno v:
In Statistiques – Santé Publique 2023:vi-vi
Autor:
Florent, Puisset, Mélanie, White-Koning, Nassim, Kamar, Antoine, Huart, Frédérique, Haberer, Hélène, Blasco, Chantal, Le Guellec, Thierry, Lafont, Anaïs, Grand, Lionel, Rostaing, Etienne, Chatelut, Jacques, Pourrat
Publikováno v:
British journal of clinical pharmacology. 76(5)
Both rituximab and plasmapheresis can be associated in the treatment of immune-mediated kidney diseases. The real impact of plasmapheresis on rituximab pharmacokinetics is unknown. The aim of this study was to compare rituximab pharmacokinetics betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a7131478f9e4956ee3bd7ce9de6018f
https://pubmed.ncbi.nlm.nih.gov/23432476
https://pubmed.ncbi.nlm.nih.gov/23432476
Publikováno v:
Bulletin du cancer. 94(4)
Compliance is a very important issue in medicine for three major reasons. Non-compliance has a considerable financial cost for health care systems. Adherence to treatment is the main link between intention to treat and the desired health outcome. Fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af9d0e0e96c9da446b0388ab9329d9ca
https://pubmed.ncbi.nlm.nih.gov/17449437
https://pubmed.ncbi.nlm.nih.gov/17449437
Autor:
Mélanie White-Koning, Nabil Maarouf, Laurence Brugières, Patricia Delafosse, Brigitte Trétarre, Danièle Sommelet, Anne-Valérie Guizard, Emmanuel Desandes, Angelina Marr, Brigitte Lacour, Christine Cotte, Michel Velten, Arlette Danzon
Publikováno v:
European Journal of Oncology Nursing
European Journal of Oncology Nursing, Elsevier, 2007, 11 (1), pp.74-81. ⟨10.1016/j.ejon.2006.04.036⟩
European Journal of Oncology Nursing, Elsevier, 2007, 11 (1), pp.74-81. 〈10.1016/j.ejon.2006.04.036〉
European Journal of Oncology Nursing, Elsevier, 2007, 11 (1), pp.74-81. ⟨10.1016/j.ejon.2006.04.036⟩
European Journal of Oncology Nursing, Elsevier, 2007, 11 (1), pp.74-81. 〈10.1016/j.ejon.2006.04.036〉
International audience; We report an adolescent cancer pathway from referral, through diagnosis and treatment, to follow-up in France. All cases of cancer among 15-19 years, diagnosed from 1988 to 1997, recorded by nine French population-based cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3be7df0a34317b043a2c7b69c081ac
https://hal.archives-ouvertes.fr/hal-00492897
https://hal.archives-ouvertes.fr/hal-00492897
Autor:
Anis Krache, Charlotte Fontan, Carine Pestourie, Manuel Bardiès, Yann Bouvet, Pierre Payoux, Etienne Chatelut, Melanie White-Koning, Anne-Sophie Salabert
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Anti-PDL1 is a monoclonal antibody targeting the programmed death-cell ligand (PD-L1) by blocking the programmed death-cell (PD-1)/PD-L1 axis. It restores the immune system response in several tumours, such as non-small cell lung cancer (NSCLC). Anti
Externí odkaz:
https://doaj.org/article/7e88c75dd0124f899fc8b11d3c6144fe
Autor:
Krache, Anis
Publikováno v:
Immunothérapie. Université Paul Sabatier-Toulouse III, 2022. Français. ⟨NNT : 2022TOU30011⟩
Immunotherapy with anti PD-L1 monoclonal antibodies is an innovative cancer treatment, used in non-small cell lung cancer (NSCLC). This antibody inhibits checkpoints inhibitors to restore the anti-tumour immune response by preventing the binding betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::0ee0ab7090797f5bc82da1e8ea7096a6
https://theses.hal.science/tel-03714177/file/2022TOU30011a.pdf
https://theses.hal.science/tel-03714177/file/2022TOU30011a.pdf
Autor:
Gallais, Fanny
Publikováno v:
Cancer. Université Paul Sabatier-Toulouse III, 2020. Français. ⟨NNT : 2020TOU30076⟩
Ibrutinib, the first-in-class Bruton Tyrosine Kinase inhibitor, is indicated for the treatment of chronic lymphocytic leukemia (CLL). CLL is characterized by the accumulation of abnormal B cells in the bone marrow, lymphoid organs and blood. Ibrutini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::53963f93843ad54b549c67f1f53cd1d8
https://tel.archives-ouvertes.fr/tel-03098547/document
https://tel.archives-ouvertes.fr/tel-03098547/document